Skip to Main Content

Paper Details

Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion.
Hepatol Int
7
2023
Author NameAffiliation
Merrill Eric GershwinAllergy and Clinical Immunology, University of California at Davis
  • 1 - 1

Datasets

Release 1.2